# EDGAR Filing Document

**Accession Number:** 0001826892
**File Stem:** 0001193125-23-008334
**Filing Date:** 2023-1
**Character Count:** 2489
**Document Hash:** 726a4432fc4e6b5a63bcda5d89af5832
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-23-008334.hdr.sgml**: 20230214

**ACCESSION NUMBER**: 0001193125-23-008334

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20230113

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** BioAtla, Inc.
- **CENTRAL INDEX KEY:** 0001826892
- **STANDARD INDUSTRIAL CLASSIFICATION:** BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
- **IRS NUMBER:** 851922320
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 11085 TORREYANA ROAD
- **CITY:** SAN DIEGO
- **STATE:** CA
- **ZIP:** 92121
- **BUSINESS PHONE:** 858-558-0708

**MAIL ADDRESS:**
- **STREET 1:** 11085 TORREYANA ROAD
- **CITY:** SAN DIEGO
- **STATE:** CA
- **ZIP:** 92121

![LOGO](g416654g0114010304431.jpg)

11085 Torreyana Road

San Diego, CA 92121

January 13, 2023

***VIA EDGAR***

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attn: Arzhang Navai, Office of Life Sciences

---

| | |
|:---|:---|
| **Re:** | **BioAtla, Inc.**<br> **Registration Statement on Form S-3**<br> **Filed January 6, 2023**<br> **File No. 333-269148**<br> **REQUEST FOR ACCELERATION OF EFFECTIVENESS** |

---

**<u>Acceleration Request</u>**

Requested Date: January 17, 2023 <br> Requested Time: 4:00 p.m. Eastern Time

Ladies and Gentlemen:

Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, BioAtla, Inc. (the "***Company***") hereby requests that the Securities and Exchange Commission (the "***Commission***") take appropriate action to declare the Company's Registration Statement on Form S**-**3 (File No. 333-269148) effective at the "Requested Date" and "Requested Time" set forth above or as soon thereafter as practicable.

The Company hereby authorizes Niki Fang, who is an attorney with the Company's outside legal counsel, Orrick, Herrington & Sutcliffe LLP, to orally modify or withdraw this request for acceleration.

The Company requests that it be notified of such effectiveness by a telephone call to Ms. Fang at (415) 773-5540.

*[Signature page follows]* 

------

---

| | |
|:---|:---|
| Sincerely, | Sincerely, |
| BIOATLA, INC. | BIOATLA, INC. |
| By: | /s/ Richard Waldron |
|  | Name: Richard Waldron |
|  | Title: Chief Financial Officer |

---

cc: Chris Vasquez, BioAtla, Inc.

Niki Fang, Esq., Orrick, Herrington & Sutcliffe LLP